Skip to main content

An official website of the United States government

You have 2 new alerts

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

info alert

Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Solicitation (Updated)
  • Updated Published Date: Oct 26, 2021 08:25 pm EDT
  • Original Published Date: Mar 04, 2020 06:02 pm EST
  • Updated Date Offers Due: May 02, 2022
  • Original Date Offers Due: Mar 04, 2020
  • Inactive Policy: Manual
  • Updated Inactive Date: May 02, 2022
  • Original Inactive Date: Oct 31, 2020
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Washington , DC 20515
    USA

Description

We appreciate your interest in partnering with BARDA.  Due to the COVID-19 response, any white papers or full proposal submissions, other than those that are in support of COVID-19, will be put into a queue.  Once the response to COVID-19 has subsided, we will resume normal review of submissions for other research areas of interests.  BARDA will not be able to meet the timelines highlighted in the Broad Agency Announcement.  Thank you for understanding this unprecedented response and delays that will occur.

The latest BARDA Broad Agency Announcement (BAA) is Amendment 29, posted on Oct 26, 2021.

Note: COVID-19 response related Areas of Interest include:

  • AOI 7.7.1 Diagnostic Assay for Human Coronaviruses
  • AOI 7.7.2 Diagnostic Assay for Detection of SARS-CoV-2 Virus
  • AOI 7.7.3 Diagnostic Assay for Detection of COVID-19 Neutralizing Antibodies
  • AOI 7.7.5 Screening Tests at Point of Care (2-minute Time to Result)

All contracting related inquiries should be sent to BARDA-BAA@hhs.gov. BARDA will continuously review and expedite COVID-19 response related white papers and full proposals. Offerors should also complete the Submission Data Integration Table.

The final white paper submission deadline is May 2, 2022. The final full proposal submission deadline is May 2, 2022, or as specified in the invitation letter.

Contact Information

Contracting Office Address

  • 200 Independence Avenue, SW
  • Washington , DC 20201
  • USA

Primary Point of Contact

Secondary Point of Contact

History